We are an autologous cell and gene therapy company focused on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. Our distinctive approach to personalized biologics is based on our proprietary autologous fibroblast technology. Fibroblasts are the most common cell in skin and connective tissue and are responsible for synthesizing extracellular matrix proteins including collagen and other growth factors, that provide structure and support. Because fibroblasts naturally reside in the localized environment of the skin and connective tissue, they represent an ideal delivery vehicle for proteins targeted to these areas. We target the underlying cause of disease by using fibroblast cells from a patient’s skin and genetically modifying them to create localized therapies that are compatible with the unique biology of the patient (i.e., which are autologous).
Company profile
Ticker
FCSC
Exchange
Website
CEO
John M. Maslowski
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
American Financial Holding Inc, Isolagen Inc
SEC CIK
Corporate docs
IRS number
870458888
Latest filings (excl ownership)
15-12B
Securities registration termination
7 Jan 20
EFFECT
Notice of effectiveness
18 Dec 19
EFFECT
Notice of effectiveness
18 Dec 19
EFFECT
Notice of effectiveness
18 Dec 19
EFFECT
Notice of effectiveness
18 Dec 19
EFFECT
Notice of effectiveness
18 Dec 19
EFFECT
Notice of effectiveness
18 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 19
Latest ownership filings
Institutional ownership, Q4 2019
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 21 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Proequities | 0.00 | $0.00 |